Literature DB >> 7784079

Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.

H Kouhara1, S Kurebayashi, K Hashimoto, S Kasayama, M Koga, T Kishimoto, B Sato.   

Abstract

To examine the biological role of fibroblast growth factor receptor 1 (FGFR1) oligomerization for its signal transduction, we construct an expression vector encoding a FGFR1-beta-galactosidase fusion protein. This vector is designed to fuse the 3'-portion of FGFR1 to beta-galactosidase. Transfection of this vector into FGFR-negative rat L6 myoblast cells results in ligand-independent inhibition of differentiation into myocytes, suggesting that FGFR1 within this fusion protein is constitutively activated. This can be confirmed by demonstrating that this fusion protein exhibits the tyrosine kinase activity and phospholipase C gamma 1 is tyrosine-phosphorylated even in the absence of ligand stimuli. Since the transfected cells also exhibit the enzyme activity of beta-galactosidase which is known to be active only in a tetramer form, this constitutive activation can be elicited by tetramerization of FGFR1. Furthermore, deletion of a region corresponding to C terminal 10 amino acids important for tetramerization of beta-galactosidase from this expression vector abolishes the constitutively active nature of FGFR1 with simultaneous loss of beta-galactosidase activity. Transfection of non-deleted expression vector into NIH3T3 cells results in acquisition of focus-forming activity while a deleted form of expression vector fails to show this activity even in the presence of basic FGF. These results would suggest that tetramerization of FGFR1 can produce a constitutively active form responsible for transformation of NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784079

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain.

Authors:  M K Webster; D J Donoghue
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Expression of fibroblast growth factor receptor-1 in rat heart H9c2 myoblasts increases cell proliferation.

Authors:  F Sheikh; Y Jin; K B Pasumarthi; E Kardami; P A Cattini
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

3.  Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.

Authors:  G C Huang; X Ouyang; R J Epstein
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Detection of targeted GFP-Hox gene fusions during mouse embryogenesis.

Authors:  A R Godwin; H S Stadler; K Nakamura; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

5.  Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene.

Authors:  Francesca Pellicano; Rachel E Thomson; Gareth J Inman; Tomoko Iwata
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

6.  A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling.

Authors:  Ling Lin; Lynn Chamberlain; Magnolia L Pak; Arvindhan Nagarajan; Romi Gupta; Lihua J Zhu; Casey M Wright; Kwun M Fong; Narendra Wajapeyee; Michael R Green
Journal:  Cancer Discov       Date:  2014-07-11       Impact factor: 39.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.